EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling

Qi-Qi Liu iD, Wei-Wei Wu, Jian Yang, Rui-Bin Wang, Ling-Ling Yuan, Pei-Zhao Peng, Mao-Yun Zeng, Ke Yu iD

Mediators of Inflammation · 2023

DOI: 10.1155/2023/9330439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, 2023. Verfasst von Qi-Qi Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Stomatological Hospital of Southwest Medical University, 2, Jiangyang Nan Road, Luzhou, China. Hauptthemen laut MEDLINE: Bone Resorption, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Peri-Implantitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Sichuan Province, Southwest Medical University, Office of Science & Technology and Talent Work of Luzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we examined the effect of the GP130-targeting molecule, LMT-28, on lipopolysaccharide- (LPS-) induced bone resorption around implants in diabetic models using in vitro and rat animal experiments. First, LMT-28 was added to osteoblasts stimulated by LPS and advanced glycation end products (AGEs), and nuclear factor-κB receptor-activating factor ligand (RANKL) and associated pathways were evaluated. Then, LMT-28 was administered by gavage at 0.23 mg/kg once every 5 days for 2 weeks to type 2 diabetic rats with peri-implantitis induced by LPS injection and silk ligature. The expression of IL-6 and RANKL was evaluated by immunohistochemistry, and the bone resorption around implants was evaluated by microcomputed tomography. The results showed that LMT-28 downregulated the expression of RANKL through the JAK2/STAT3 signaling pathway in osteoblasts stimulated by LPS and AGEs, reduced bone resorption around implants with peri-implantitis, decreased the expression of IL-6 and RANKL, and decreased osteoclast activity in type 2 diabetic rats. This study confirmed the ability of LMT-28 to reduce LPS-induced bone resorption around implants in diabetic rats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone ResorptionDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2Peri-ImplantitisAnimalsRatsCytokine Receptor gp130Glycation End Products, AdvancedInterleukin-6Janus Kinase 2LipopolysaccharidesOsteoclastsRANK LigandSignal TransductionX-Ray MicrotomographyOxazolidinones

Substanzen

Cytokine Receptor gp130Glycation End Products, AdvancedInterleukin-6Janus Kinase 2LipopolysaccharidesRANK LigandJak2 protein, ratLMT-28Oxazolidinones

Autor:innen und Institutionen

  • The Affiliated Stomatological Hospital of Southwest Medical University, 2, Jiangyang Nan Road, Luzhou, China.

ORCID-Profile: Qi-Qi Liu, Ke Yu

Förderung

  • Key Research and Development Program of Sichuan Province
  • Southwest Medical University
  • Office of Science & Technology and Talent Work of Luzhou

Zitieren

APA

Liu, Q. Q., Wu, W. W., Yang, J., Wang, R. B., Yuan, L. L., Peng, P. Z., Zeng, M. Y., & Yu, K. (2023). A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling. Mediators of Inflammation. https://doi.org/10.1155/2023/9330439

Vancouver

Liu QQ, Wu WW, Yang J, Wang RB, Yuan LL, Peng PZ, et al. A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling. Mediators of Inflammation. 2023. doi:10.1155/2023/9330439

BibTeX
@article{Liu2023,
  author = {Liu, Qi-Qi and Wu, Wei-Wei and Yang, Jian and Wang, Rui-Bin and Yuan, Ling-Ling and Peng, Pei-Zhao and Zeng, Mao-Yun and Yu, Ke},
  title = {A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling},
  journal = {Mediators of Inflammation},
  year = {2023},
  doi = {10.1155/2023/9330439}
}
Kostenlos starten →